CNMD guides 6%-8% H2 2024 revenue growth on margin expansion
Management cites strong Q2 performance and confidence in 6%-8% revenue growth for H2 2024, citing AirSeal, BioBrace and international expansion. Margin expansion and robust free cash flow supported by sales and R&D investments.